Metabolic Stress-Induced Phosphorylation of KAP1 Ser473 Blocks Mitochondrial Fusion in Breast Cancer Cells
Abstract
Mitochondrial dynamics during nutrient starvation of cancer cells likely exert profound effects on their capability for metastatic progression. Here, we report that KAP1 (TRIM28), a transcriptional coadaptor protein implicated in metastatic progression in breast cancer, is a pivotal regulator of mitochondrial fusion in glucose-starved cancer cells. Diverse metabolic stresses induced Ser473 phosphorylation of KAP1 (pS473-KAP1) in a ROS- and p38-dependent manner. Results from live-cell imaging and molecular studies revealed that during the first 6 to 8 hours of glucose starvation, mitochondria initially underwent extensive fusion, but then subsequently fragmented in a pS473-KAP1-dependent manner. Mechanistic investigations using phosphorylation-defective mutants revealed that KAP1 Ser473 phosphorylation limited mitochondrial hyperfusion in glucose-starved breast cancer cells, as driven by downregulation of the mitofusin protein MFN2, leading to reduced oxidative phosphorylation and ROS production. In clinical specimens of breast cancer, reduced expression of MFN2 corresponded to poor prognosis in patients. In a mouse xenograft model of human breast cancer, there was an association in the core region of tumors between MFN2 downregulation and the presence of highly fragmented mitochondria. Collectively, our results suggest that KAP1 Ser473 phosphorylation acts through MFN2 reduction to restrict mitochondrial hyperfusion, thereby contributing to cancer cell survival under conditions of sustained metabolic stress.
Additional Information
© 2016 American Association for Cancer Research. Received October 20, 2015; revised May 26, 2016; accepted June 15, 2016; published Online First June 30, 2016. No potential conflicts of interest were disclosed. Authors' Contributions: Conception and design: C.-T. Cheng, C.-Y. Kuo, C.-F. Li, D.K. Ann Development of methodology: C.-T. Cheng, C.-Y. Kuo, Y. Chung, D.K. Ann Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): C.-T. Cheng, C.-Y. Kuo, C. Ouyang, C.-F. Li, Y. Chung Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): C.-T. Cheng, C.-Y. Kuo, C. Ouyang, C.-F. Li, D.C. Chan, H.-J. Kung, D.K. Ann Writing, review, and/or revision of the manuscript: C.-T. Cheng, C.-Y. Kuo, C. Ouyang, D.C. Chan, H.-J. Kung, D.K. Ann Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): C.-T. Cheng, C. Ouyang, D.K. Ann Study supervision: C.-T. Cheng, D.K. Ann This study was financially supported by National Institute of Health Research Grants R01DE10742, R01DE14183, and The Mary Kay Foundation Research Grant number 005-13 (D.K. Ann), Ministry of Health and Welfare Research Grant MOHW103-TD-M-111-102001 (C.-F. Li), R01CA165263, R01CA150197, MOHW104-TDU-M-212-13304, MOST102-2320-B-400-018-MY3, MOST104-2321-B-400-009, NHRI05A1-MGPP15-014 (H.-J. Kung), and P30CA33572. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. We are sincerely grateful to Drs. Emily Wang and Art Riggs for their helpful suggestions and critical reading of manuscript, Ms. Lucy Brown of the Analytical Cytometry Core for flow cytometry analyses, Dr. Brian Armstrong and Ms. Tina Patel of the Light Microscopy Core for microscopy analyses, Mr. Austin Changou for processing time lapse imaging analyses, Drs. Xiwei Wu and Jinhui Wang and Mr. Charles Warden of Functional Genomics Core for RNA-seq data analyses, Ms. Tina Montgomery and Ms. Sofia Loera of Pathology Core for immunohistochemical analyses, Dr. Tzu-Ju Chen for pathological evaluation, Drs. Marcia Miller, Zhuo Li, and Ricardo Zerda of Electron Microscopy Core and Mr. Kevin Chi for EM image analysis and members of Dr. Ann's laboratory for helpful discussions and Dr. Nancy Linford for editing.Attached Files
Accepted Version - 0008-5472.CAN-15-2921.full.pdf
Supplemental Material - 157219_2_supp_3509776_474zs1.docx
Supplemental Material - 157219_2_supp_3509784_575zs2.pdf
Supplemental Material - 157219_2_video_3509799_l7lzll.mov
Supplemental Material - 157219_2_video_3509800_t7tztt.mov
Supplemental Material - 157219_2_video_3509801_w7wzww.mov
Supplemental Material - 157219_2_video_3509802_f7fzff.mov
Files
Name | Size | Download all |
---|---|---|
md5:238be8d3866e8429df0072b56cc6bb29
|
24.1 kB | Download |
md5:01c9325d3d941840f197c3205cca53a4
|
1.5 MB | Preview Download |
md5:1c58ef7c173e1068562a6e91ed854955
|
889.3 kB | Download |
md5:ff0849c06137b09b4ac5ad932a8d6403
|
518.4 kB | Download |
md5:f13f07291fddf7477b6b1831a307f071
|
3.8 MB | Preview Download |
md5:0e9ece6b6078b788e53fb0fc32ca2ba5
|
711.9 kB | Download |
md5:3a0202d38712bdf1ff1e67fdb3e9e06b
|
475.1 kB | Download |
Additional details
- PMCID
- PMC5316485
- Eprint ID
- 70330
- DOI
- 10.1158/0008-5472.CAN-15-2921
- Resolver ID
- CaltechAUTHORS:20160914-080907190
- NIH
- R01DE10742
- NIH
- R01DE14183
- Mary Kay Foundation
- 005-13
- Ministry of Health and Welfare (Taipei)
- MOHW103-TD-M-111-102001
- NIH
- R01CA165263
- NIH
- R01CA150197
- Ministry of Health and Welfare (Taipei)
- MOHW104-TDU-M-212-13304
- Ministry of Science and Technology (Taipei)
- MOST102-2320-B-400-018-MY3
- Ministry of Science and Technology (Taipei)
- MOST104-2321-B-400-009
- NIH
- NHRI05A1-MGPP15-014
- National Cancer Institute
- P30CA33572
- Created
-
2016-09-28Created from EPrint's datestamp field
- Updated
-
2022-04-26Created from EPrint's last_modified field